Home Newsletters Cell Therapy News The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection...

The Combination Immunotherapy of TLR9 Agonist and OX40 Agonist via Intratumoural Injection for Hepatocellular Carcinoma

0
Orthotopic and ectopic hepatocellular carcinoma models were constructed by implanting Hepa1-6 cells at different body sites of mice. Immune agents were administrated via three ways, including intratumoral injection into one site of the tumor, intraperitoneal injection, and subcutaneous injection.
[Journal of Hepatocellular Carcinoma]

Sorry, but the selected Zotpress account can't be found.

Abstract
Exit mobile version